Pharmacotherapeutic advances for chronic idiopathic constipation in adults
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2150076
Abstract: ABSTRACT Introduction Chronic idiopathic constipation is a common gastrointestinal disorder whose treatment is still far from being satisfactory for patients. Osmotic laxatives, in particular polyethylene glycol, are the first-line approach, but new emerging pharmacological agents… read more here.
Keywords: constipation adults; chronic idiopathic; pharmacotherapeutic advances; constipation ... See more keywords
Pharmacotherapeutic advances for splenomegaly in myelofibrosis
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2192350
Abstract: ABSTRACT Introduction Myelofibrosis is a hematologic malignancy with a variety of clinical manifestations including splenomegaly, which is present in approximately 80% of newly diagnosed patients. JAK inhibitors are the mainstay of pharmacologic treatment for splenomegaly… read more here.
Keywords: splenomegaly myelofibrosis; pharmacotherapeutic advances; advances splenomegaly; myelofibrosis ... See more keywords